Recon Therapeutics announced as a top 20 TEDMED start-up for 2015. "TEDMED celebrates the ideas behind this progress in a program called The Hive, which is dedicated to celebrating the power of imagination and human potential" Read more here


Recon Therapeutics competes at 2015 MassChallenge. "The 200+ startups that will be entering our 2015 accelerator include many of the highest-impact startups in the world” Read more here


Recon Therapeutics selected as a 2015 Open Minds team for showcase in DC. "Recon Therapeutics has developed a viable, intuitive, and scalable solution that addresses the complexities involved with delivering biologics at-home" Read more here


Recon Therapeutic's Christopher Lee listed in Forbes 30 under 30 in healthcare for 2015. "Recon Therapeutics, allows powdered biotech drugs to be automatically mixed within a syringe using a pressurized water chamber. It is funded by $70,000 of non-dilutive grants and student awards." Read more here


Recon Therapeutics highlighted in MIT's  Spectrum making drug delivery safer and more patient friendly. "Recon’s LyoKit Drug Reconstitution System relieves the patient of the responsibility of mixing and measuring their drugs. A compounding pharmacy sets the dosage; patients receive a standard syringe with an external pressurized water chamber, allowing for a one-step reconstitution process." Read more here


Recon Therapeutics highlighted in Inc.com as a top young emerging global entrepreneurs. Recon among the "50 Emerging Global Entrepreneurs to Watch". Read more here


Recon Therapeutics selected as a Kairos 50 member by the Kairos Society. The Kairos Global Summit brings together global leaders and young entrepreneurs to bring innovations to market. Read more here


Recon Therapeutics selected as a stage 2 e-team winner by VentureWell, formerly the NCIIA. "The Lyokit Drug Reconstitution System differentiates itself by being highly intuitive to use, reconstituting biologics with simple one finger actuation..." Read more here


Recon Therapeutics among the BMEIdea 2014 winners at the MDEA ceremony. "Competitions allow medical device companies to become familiar with the quality and commercialization potential of student design projects..." Read more here


NCIIA: Recon Therapeutics are BMEIdea 2014 Finalists. "Recon Therapeutics has incorporated as a LLC and filed a full utility patent application. They have complete a first pass design freeze and developed a beta prototype, which has been designed for manufacturing..." Read more here


Recon Therapeutics among Stage 1 E-Teams Grantees for 2014. "NCIIA defines an E-Team as a multidisciplinary group of students, faculty, and industry mentors working together to bring a technology-based invention (product or service) to market..." Read more here


2014 MIT IDEAS Global Challenge Winners. "This team has developed a new drug delivery technology that simplifies drug reconstitution between a lyophilized drug and sterile solvent at the point of care, reducing patient mistakes and improving adherence..." Read more here


Harvard Innovation Lab: Deans' Health and Life Sciences Challenge 2014 Finalists. "The Deans' Health and Life Sciences Challenge is designed to support students, postdoctoral and clinical fellows develop, test, validate and execute innovative solutions that will help improve health delivery and patient lives..." Read more here 


Here's a video on how our device helps patients.